Xconomy’s Digital Events →
Robin Heffernan, CEO and co-founder of Circulation. Photo courtesy of Circulation.
Sponsored · Webinar
Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates
Sponsored · Whitepaper
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
From Our Editors · Special Report
Becoming the Cell & Gene Therapy Hub
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.